Is there any clinical trial done on Oncozac®?
Ans: Preclinical studies have already conducted on Oncozac®. Results clearly demonstrated that Oncozac® contained absorbable peptidoglucan (APG) and could boost the human immunity so as to alleviate the side effects caused by the orthodox cancer treatment. Its immunostimulatory activity is 6 times higher than other Yunzhi products in the market. While a large scale clinical trial is being organized, the clinical outcome from some small scale trials and case investigation is consistent with that of the preclinical testing.
